SLC5A7 and colorectal carcinoma: Our results revealed that SLC5A7 promotor methylation mediated the inactivation of SLC5A7 in CRC, and that SLC5A7 methylation can be utilized as a valuable biomarker for predicting the prognosis of CRC patients.